A VAMS‐based LC–MS/MS method for precise cenobamate quantification in epilepsy (patients)
Epilepsia Open · 2024-12 · 9 (6) · 2144-2153
DOI: 10.1002/epi4.12927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia Open, online erschienen am 19.09.2024. Verfasst von Federica Pigliasco und 13 weiteren Autor:innen. Beteiligte Einrichtung: Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Carbamates, Anticonvulsants, Epilepsy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: 5 × 1000 in support of Health Research, PNRR-MUR-M4C2 PE0000006 Research Program "MNESYS"-A multiscale integrated approach to the study of the nervous system in health and disease, Italian Ministry of Health.
Abstract (Originalsprache)
Objective
Cenobamate (CNB), a recently approved antiseizure medication by the European Medicines Agency (EMA), serves as an adjunctive therapy for focal‐onset seizures in adult patients unresponsive to at least two other treatments. Administered in polytherapy, CNB can potentially interact with co‐administered drugs in epilepsy patients, necessitating dose adjustments and the need for effective therapeutic drug monitoring (TDM).
Methods
In this study, we introduce a novel LC–MS/MS method for precise CNB quantification using Volumetric Absorptive Microsampling (VAMS), following validation according to ICH guidelines M10. VAMS samples are efficiently extracted with 200 μL of methanol, with chromatographic separation achieved using an Acquity UPLC HSS PFP column. The method's efficacy was confirmed through its application to real samples from adult CNB‐treated patients.
Results
Our results demonstrate that the method exhibits linearity within the range of 0.05–30 mg/L, with intra‐ and inter‐run precision ranging from 1% to 8% and accuracy from 1% to 10% based on 30 μL of sample. Furthermore, CNB stability in VAMS is confirmed for up to 15 days at 25°C and −20°C. Importantly, no significant difference was observed between CNB concentrations in VAMS samples and those in plasma obtained from venous blood. Significance This VAMS‐based LC–MS/MS method presents a robust alternative for TDM in CNB‐treated patients. Future investigations should explore CNB concentrations in capillary blood and assess their correlation with plasma levels to further enhance its clinical utility. Plain Language Summary Cenobamate is an antiepileptic drug and used for treatment of focal‐onset seizures in adult patients (≥18 age). TDM can prevent drug interactions and minimize drug toxicity. The aim of this work is to evaluate volumetric absorptive microsampling (VAMS) from capillary blood as an alternative strategy for TDM in patients treated with the newly antiepileptic drug. Our method is suitable for TDM, and this study suggests that VAMS allows monitoring of cenobamate concentration and can offer valuable support for personalized therapy in refractory epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
- IRCCS Istituto Giannina Gaslini, Gaslini Trial Centre, Genova, Italy.
- Pharmacology and Toxicology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy.
- Clinical Pharmacology Unit, Ente Ospedaliero Ospedali Galliera, Genoa, Italy.
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
- SSD Laboratory Medicine - SMEL122, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
ORCID-Profile: Federica Pigliasco, Alessia Cafaro, Linda Molteni, Pasquale Striano
Förderung
- 5 × 1000 in support of Health Research
- PNRR-MUR-M4C2 PE0000006 Research Program "MNESYS"-A multiscale integrated approach to the study of the nervous system in health and disease
- Italian Ministry of Health
- Ministero della Salute
Zitieren
APA
Pigliasco, F., Cafaro, A., Barco, S., Biondi, M., Stella, M., Mattioli, F., Riva, A., de Grazia, U., Molteni, L., Micalizzi, E., Villani, F., Striano, P., Bandettini, R., & Cangemi, G. (2024). A VAMS‐based LC–MS/MS method for precise cenobamate quantification in epilepsy (patients). Epilepsia Open, 9(6), 2144-2153. https://doi.org/10.1002/epi4.12927
Vancouver
Pigliasco F, Cafaro A, Barco S, Biondi M, Stella M, Mattioli F, et al. A VAMS‐based LC–MS/MS method for precise cenobamate quantification in epilepsy (patients). Epilepsia Open. 2024;9(6):2144-2153. doi:10.1002/epi4.12927
BibTeX
@article{Pigliasco2024,
author = {Pigliasco, Federica and Cafaro, Alessia and Barco, Sebastiano and Biondi, Margherita and Stella, Manuela and Mattioli, Francesca and Riva, Antonella and de Grazia, Ugo and Molteni, Linda and Micalizzi, Elisa and Villani, Flavio and Striano, Pasquale and Bandettini, Roberto and Cangemi, Giuliana},
title = {A VAMS‐based LC–MS/MS method for precise cenobamate quantification in epilepsy (patients)},
journal = {Epilepsia Open},
year = {2024},
volume = {9},
number = {6},
pages = {2144--2153},
doi = {10.1002/epi4.12927}
}
EUVIMED